Q3 FY2026 · ended Sep 30, 2026 · Revenue $842.00M, +19.2% YoY · Filed Nov 4, 2026
Insulet Corporation (PODD) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $842.0 million and net income of $141.1 million. Free cash flow was $66.4 million. As of Sep 30, 2026 it held $584.4 million in cash and investments and $44.2 million in total debt.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- PODD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Acton, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1145197
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $842.0M | $801.7M | $761.7M | $783.8M | $706.3M |
| Operating income | $189.8M | $129.7M | $122.1M | $146.3M | $117.7M |
| Net income | $141.1M | $95.0M | $91.1M | $101.6M | $87.6M |
| Diluted EPS | $2.03 | $1.37 | $1.30 | $1.44 | $1.24 |
| Operating cash flow | $123.5M | $88.4M | $113.8M | $183.3M | $125.7M |
| Free cash flow | $66.4M | $55.9M | $89.5M | $48.2M | $100.1M |
| Total assets | $3.4B | $3.2B | $3.0B | $3.2B | $3.0B |
| Total liabilities | $1.8B | $1.7B | $1.7B | $1.7B | $1.6B |
| Stockholders' equity | $1.6B | $1.4B | $1.3B | $1.5B | $1.4B |
| Cash and investments | $584.4M | $534.9M | $480.4M | $716.1M | $757.4M |
| Total debt | $44.2M | $26.3M | $21.6M | $70.3M | $79.9M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Sep 21, 2026 | Sep 21, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 16, 2026 | Sep 14, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 10, 2026 | Sep 3, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
All 1002 Insulet Corporation SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.